Literature DB >> 19772616

The rK39 strip test is non-predictor of clinical status for kala-azar.

Dharmendra P Singh1, Shyam Sundar, Tribhuban M Mohapatra.   

Abstract

BACKGROUND: The rK39 strip test is reported to be simple, sensitive, specific, non-invasive and economical test. Since this method is supposed to be patient friendly, it may easily be accepted for sero-epidemiological surveys. An attempt was made to evaluate the role of rK39 strip test in pre and post treatment phases of Kala azar, as a diagnostic and prognostic marker, in addition to other laboratory investigations, in order to evaluate its role in sero-epidemiological surveys.
FINDINGS: A total of 210 cases were selected for the study. One hundred clinically and parasitologically confirmed cases were corroborated with other hematological profiles. The formol-gel test was included along with well matched control group comprising of normal endemic controls (50), non-endemic normals (20) and other febrile cases (40). All groups were tested by rK39 strip test. Fifty Kala azar cases were followed up after completion of successful treatment. They were subjected to rK39 strip test after 0, 90 and 180 days of completion of successful treatment.The rK39 showed sensitivity, specificity, PPV, NPV, and diagnostic accuracy of 98% (95% CI 91.7-100), 100%, 100%, 90% (95% CI 66-100) and 98% (95% CI 92.6-100) respectively. All the 50 cured followed up cases showed positive result by rK39 strip test even after 180 days of completion of successful treatment.
CONCLUSION: The test seems an ideal qualitative test for the diagnosis of kala-azar. But for sero-epidemiological studies the test may be used with other parameters. Alternatively a quantitative ELISA using rK39 antigen may be used.

Entities:  

Year:  2009        PMID: 19772616      PMCID: PMC2758890          DOI: 10.1186/1756-0500-2-187

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


Background

Visceral Leishmaniasis (VL) is a potentially fatal disease, caused by Leishmania donovani complex. The disease is endemic in 88 countries spread over 5 continents with a total of 12 million cases and 350 million people at risk [1]. Of all the VL cases, more than 90% are from India, Nepal, Bangladesh, Southern Sudan and Northeast Brazil. In India, VL is endemic in Bihar, Eastern part of India, Tamil Nadu, Jamu and Kashmir. For decades, detection of the parasite has been considered to be the definitive diagnosis of this disease. It requires invasive procedure to detect the parasite in the tissue, i.e. spleen, bone-marrow and lymph node. Although it is the gold standard for the diagnosis of VL but the procedure is cumbersome, risky and very difficult to apply in field conditions. To obviate these procedures various serological tests have been developed, evaluated and tried. These tests have the advantage of being safe, less invasive and can be done in large numbers of samples. Nonspecifc methods, such as Napier's formol gel (aldehyde test) and the Chopra antimony test, which depend upon raised globulin levels, have been used in the diagnosis of VL for several decades. Lack of specificity, as well as varying sensitivities, render them highly unreliable. In the past, conventional methods of antibody detection like immunodiffusion [2], complement fixation test [3], indirect hemagglutination test and countercurrent immunoelectrophoresis [4] were being used as diagnostic tool for VL. However, apart from practical difficulties at peripheral laboratories, the sensitivities and specificities of most of the above tests had been the limiting factors. These tests are no longer in use for routine diagnosis of VL. Indirect fluorescent antibody test was found to be highly sensitive and specific but difficult to apply in field conditions. ELISA is a versatile test. It is easy to apply and highly sensitive but its specificity depends on the type of antigen used [5]. Latex agglutination test (KATEX), for the detection of leishmanial antigen in urine of patients with VL showed high specificity but equivocal sensitivity [6]. Direct agglutination test (DAT) is a sensitive test and well adapted to screening of a large population, especially using its variant referred to as, "Fast Agglutination Screening Test". It has been advocated for field use [7-9]. However, simple format of rK39 strip test suggests its clear advantages for use in peripheral health services compared to the current FD-DAT format. The rk39 strip test is a simple, rapid and accurate test with good sensitivity and specificity, which can be used without any specific expertise. Recently, some authors have advocated its use for the sero-epidemiological surveys [10].

Methods

The study was carried out in Muzaffarpur district of Bihar state, India, for comparative evaluation of the sensitivity, specificity, predictive values (positive and negative) and diagnostic accuracy of rK39 test. A total of 210 subjects were investigated. The study group comprised of 100 clinically, hematologically and parasitologically confirmed patients, 50 endemic normals (mostly apparently healthy first degree relative of patients residing in the endemic area), 20 healthy individuals from Europe where kala-azar is not endemic (non endemic controls) and a group of 40 individuals with history of febrile illness (tuberculosis, malaria and enteric fever) were investigated for kala-azar. All individuals were subjected to rK39 strip test. The cases presented had clinical symptoms and signs suggestive of kala-azar i.e. fever, splenomegaly and anaemia. Routine investigations were carried out to exclude other etiologies of the fever with hepato-splenomegaly. The final diagnosis of VL was established by Karnofsky score, WBC count, hemoglobin assay, fomol-gel test and demonstration of parasites in splenic aspirates. These patients were bled on first encounter before and after specific treatment. All patients were provided a standard treatment with amphotericin B (Sarabhai Chemicals, Vadodara, India) in 1 mg/kg infusions on alternate days up to a total of 15 infusions. After completion of treatment the patients were free of symptoms. The leucocytes count restored and the formol-gel test showed a tendency of negative reaction. Out of 100 treated Kala azar cases, 50 cases (easily accessible) were further followed up after elaborate scrutiny, to asses the rK39 antibodies by strip test. Approximately 5 to 6 ml of blood was collected from each treated patient and subjected to rK39 strip test for demonstration of antibodies. Easily accessible among treated patients were monitored every 3 months for 6 months by rK39 strip test (0, 90, & 180 days). Their case history were documented. Formol-gel test was carried out by adding a drop of formalin (40%) in two ml of serum and incubated for 20 minutes; a positive result was indicated by appearance of jellification of milky white opacity. The rK39 strip was provided by In Bios International, Inc. 562 1st Ave. South, suite 600 Seattle, WA 98104 USA. The strip for VL assay is a qualitative membrane based immunoassay for the detection of antibodies to visceral leishmaniasis in human serum. The test was conducted according to instruction provided by manufacturers. In brief, 20 μl serum was placed on pad. Following this, 2-3 drops of wash buffer (provided) was added to pad and the mixture was allowed to migrate up the strip by capillary action. The result was read within 10 minutes. There are two pink lines in a positive result; the upper one is control and lower one is the test. The appearance of only one pink line means a negative result when this is upper line; but if the one pink line is the lower line (test) this means an invalid result.

Statistical analysis

The serological data thus obtained were statistically analyzed after entry in EPI-info (version-6) and SPSS statistical package. The Fleiss Quadratic method was used for the calculation of confidence interval of proportions. The sensitivity, specificity, predictive values (positive and negative) and diagnostic accuracy were mathematically calculated as follows: sensitivity = (true positive/true positive + false negative) × 100; Specificity = (true negative/true negative + false positive) × 100; Positive predictive value (PPV) = (true positive/total positive) × 100; Negative predictive value (NPV) = (true negative/total negative) × 100; Diagnostic accuracy = (true positive + true negative/grand total) × 100. The study was approved by the Ethical committee of Institute of Medical Sciences, Banaras Hindu University. Written consent was obtained from all the subjects.

Results

Of the 100 parasitologically proven index cases, 98 cases were found to be positive for rK39 antibodies. Among the apparently healthy endemic normals10% (5 out of 50) showed positivity for rK39 strip test while none from non-endemic area showed positive reaction. No cross reactivity was found between VL cases and other febrile cases. A detailed clinical and laboratory findings along with the rK39 results has been depicted in the Table 1. It was observed that the rK39 strip test had sensitivity, specificity, PPV, NPV, and diagnostic accuracy of 98% (95% CI 91.7-100), 100%, 100%, 90% (95% CI 66-100) and 98% (95% CI 92.6-100) respectively.
Table 1

Clinical and laboratory features along with rK39 results of patients with visceral Leishmaniasis and Controls

Study entry
VL patientsControls
Pre-treatedPost-treated (180 day)
No.10050110
Age (years)26 ± 4.5-27 ± 4.1
Duration of illness (months)4.4 ± 0.45--
Weight (kg)40.1 ± 6.645.4 ± 5.260 ± 5.4
Karnofsky score71.8 ± 2.585.4 ± 2.7100
Spleen size(cm)8.4 ± 2.44.0 ± 0.6-
Splenic aspirate score2.9 ± 0.4--
WBC count(× 103/mm3)3.49 ± 0.596.4 ± 0.69.1 ± 2.3
Hemoglobin (g/dL)6.9 ± 0.4811.2 ± 0.7614.2 ± 2.1
Platelet count(× 103/mm3)72 ± 0.35270 ± 0.5254 ± 23
rK39 positivity98*50*5*

*indicates total no. of positive.

Clinical and laboratory features along with rK39 results of patients with visceral Leishmaniasis and Controls *indicates total no. of positive. The rK39 strip test showed positive result in all the 50 cases after 180 days whereas formol-gel test showed 80%, 70%, and 50% positive result after 0, 90, 180 days respectively (Figure 1).
Figure 1

Comparative evaluation of Formol-gel test and rK39 strip test in post treated cases.

Comparative evaluation of Formol-gel test and rK39 strip test in post treated cases.

Discussion

The present study was conducted on 210 subjects to evaluate rK39 strip test as a diagnostic and prognostic tool for kala-azar. It showed 98% sensitivity and 100% specificity with confirmed VL cases whereas it showed negative reaction with non-endemic normals. Five subjects from an endemic area were found to be positive by rK39 strip test. This may be due to the fact that these persons belonged to the same area having the same environment. The presence of antibody in these cases may indicate either subclinical infection or they may be during the incubation period of the disease or they were partially treated by the local quacks [11]. On the contrary, all the febrile cases showed non-reactive results by this method. This result corroborates with the findings of other workers, thereby suggesting that it is an ideal format for use under field conditions as it is quick and no special equipment is needed [12,13]. On the other hand, the study conducted in Sudan showed lower sensitivity and specificity of this test [14]. The reason for this difference in sensitivity may be due to difference in antibody responses observed in different ethnic groups [10,15]. With 98% diagnostic accuracy and 100% PPV as observed in this study, it proves that rK39 strip test is a good diagnostic tool qualitatively. In the present study, fifty successfully treated individuals were followed up for six months. All these patients showed positive reaction by rK39 strip till 6 months. It indicates persistence of antibodies against rK39 antigen. This observation was supported in some studies performed in successfully treated cases for the detection of antibodies against rK39 antigen by ELISA [13,16]. In its present form, the rK39 strip test has the potential to be used as a suitable method for diagnosis of VL. For screening as a sero-epidemiological tool it has some important limitations as antibody detection cannot discriminate between past and current infection. Positive result may be due to previous infection, relapse or subclinical infection. It may not have relevance in predicting the current status of the disease in an epidemiological survey. Since some authors [10] advocated the use of this test in epidemiological surveys it may not be addressed alone. Rather, the test may be corroborated with appropriate clinical examination and patient interview.

Conclusion

This test used as such can only give an estimated idea about the proportion of people that have had exposure to leishmania parasite which eventually may suggest the transmission dynamics of the disease that can be used for working out the disease control strategies. An alternative method such as semi quantitative rK39 strip test or quantitative ELISA with rK39 antigen may be useful for sero-epidemiological surveys.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

DPS conducted the study as part of thesis for the degree of master of Medicine and provided expertise of data analysis and manuscript preparation. SS provided the clinical cases and data. TMM supervised the study and provided expertise in statistical analysis and manuscript preparation. All authors read and approved the revised final manuscript.
  14 in total

1.  Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan.

Authors:  E E Zijlstra; Y Nur; P Desjeux; E A Khalil; A M El-Hassan; J Groen
Journal:  Trop Med Int Health       Date:  2001-02       Impact factor: 2.622

2.  Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis.

Authors:  Z J Attar; M L Chance; S el-Safi; J Carney; A Azazy; M El-Hadi; C Dourado; M Hommel
Journal:  Acta Trop       Date:  2001-01-15       Impact factor: 3.112

3.  The direct agglutination test for diagnosis of visceral leishmaniasis under field conditions in Sudan: comparison of aqueous and freeze-dried antigens.

Authors:  E E Zijlstra; O F Osman; H W Hofland; L Oskam; H W Ghalib; A M el-Hassan; P A Kager; S E Meredith
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Nov-Dec       Impact factor: 2.184

4.  Leishmania/HIV co-infection. Epidemiological analysis of 692 retrospective cases.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1997-02-21

5.  The role of counter immunoelectrophoresis as a diagnostic tool in kala-azar.

Authors:  B K Aikat; S Sehgal; R C Mahajan; A G Pathania; P K Bhattacharya; S Sahaya; A B Choudhury; N Pasricha; L S Prasad
Journal:  Indian J Med Res       Date:  1979-10       Impact factor: 2.375

6.  A complement fixation test for visceral leishmaniasis using homologous parasite antigen I.

Authors:  W T Hockmeyer; B T Wellde; C L Sabwa; D H Smith; P H Rees; P A Kager
Journal:  Ann Trop Med Parasitol       Date:  1984-10

7.  Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen.

Authors:  Sarman Singh; Veena Kumari; Niti Singh
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

8.  rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection.

Authors:  E E Zijlstra; N S Daifalla; P A Kager; E A Khalil; A M El-Hassan; S G Reed; H W Ghalib
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

9.  Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis.

Authors:  S Singh; A Gilman-Sachs; K P Chang; S G Reed
Journal:  J Parasitol       Date:  1995-12       Impact factor: 1.276

10.  Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis.

Authors:  S E Meredith; N C Kroon; E Sondorp; J Seaman; M G Goris; C W van Ingen; H Oosting; G J Schoone; W J Terpstra; L Oskam
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

View more
  9 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  A Platform for the Detection of Trypanosomes via Selective Small Molecule Recognition.

Authors:  Ellen D Beaulieu; Lori L Olson; Mary J Tanga
Journal:  ACS Med Chem Lett       Date:  2011-04-18       Impact factor: 4.345

3.  Effect of Health Care on Quality of Life among Human Immunodeficiency Virus Infected Adults With and Without Visceral Leishmaniasis in northwest Ethiopia: A Longitudinal Follow-Up Study.

Authors:  Mekuriaw Alemayehu; Mamo Wubshet; Nebiyu Mesfin; Abebaw Gebayehu
Journal:  Am J Trop Med Hyg       Date:  2018-01-18       Impact factor: 2.345

4.  In search of an ideal test for diagnosis and prognosis of kala-azar.

Authors:  Dharmendra P Singh; Rahul K Goyal; Rahul K Singh; S Sundar; Tribhuban M Mohapatra
Journal:  J Health Popul Nutr       Date:  2010-06       Impact factor: 2.000

Review 5.  Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease.

Authors:  Marleen Boelaert; Kristien Verdonck; Joris Menten; Temmy Sunyoto; Johan van Griensven; Francois Chappuis; Suman Rijal
Journal:  Cochrane Database Syst Rev       Date:  2014-06-20

6.  Detection of Immunoglobulin G1 Against rK39 Improves Monitoring of Treatment Outcomes in Visceral Leishmaniasis.

Authors:  Guy Mollett; Bruno C Bremer Hinckel; Tapan Bhattacharyya; Tegwen Marlais; Om Prakash Singh; Pascal Mertens; Andrew K Falconar; Sayda El-Safi; Shyam Sundar; Michael A Miles
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

7.  Isolation and characterisation of Leishmania donovani protein antigens from urine of visceral leishmaniasis patients.

Authors:  Tegwen Marlais; Tapan Bhattacharyya; Callum Pearson; Bathsheba L Gardner; Safiyyah Marhoon; Stephanie Airs; Kiera Hayes; Andrew K Falconar; Om Prakash Singh; Steven G Reed; Sayda El-Safi; Shyam Sundar; Michael A Miles
Journal:  PLoS One       Date:  2020-09-14       Impact factor: 3.240

8.  Production of a kinesin-related recombinant protein (Lbk39) from Leishmania braziliensis by Leishmania tarentolae promastigotes and its application in the serodiagnosis of leishmaniasis.

Authors:  Lígia Moraes Barizon de Souza; Joyce Carvalho; Michelle D Bates; Ricardo Rasmussen Petterle; Vanete Thomaz-Soccol; Paul Andrew Bates
Journal:  One Health       Date:  2019-10-31

9.  Molecular Tracking of the Leishmania Parasite.

Authors:  Srija Moulik; Shilpa Sengupta; Mitali Chatterjee
Journal:  Front Cell Infect Microbiol       Date:  2021-02-22       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.